(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-19 View latest technical analysis
10 day averaged volume of Biomarin Pharmaceutical is 1185748
Date | Daily Closing Price | Open | High | Low | Volume |
19 Fri Jul 2024 | 84.09 | 83.16 | 84.20 | 83.11 | 1.589 times |
18 Thu Jul 2024 | 83.34 | 84.83 | 86.24 | 83.32 | 1.09 times |
17 Wed Jul 2024 | 84.66 | 85.49 | 85.94 | 84.20 | 0.903 times |
16 Tue Jul 2024 | 85.89 | 85.17 | 85.92 | 84.73 | 0.926 times |
15 Mon Jul 2024 | 84.59 | 85.19 | 85.69 | 84.23 | 0.913 times |
12 Fri Jul 2024 | 85.02 | 84.04 | 85.75 | 83.38 | 1.074 times |
11 Thu Jul 2024 | 83.91 | 82.76 | 84.59 | 82.09 | 1.27 times |
10 Wed Jul 2024 | 82.29 | 83.24 | 83.24 | 82.21 | 1.064 times |
09 Tue Jul 2024 | 82.98 | 82.55 | 83.56 | 82.12 | 0.815 times |
08 Mon Jul 2024 | 82.68 | 81.71 | 83.57 | 81.37 | 1.217 times |
My analysis of stock is bullish for shortterm, and stock might move up till 84.9 or till 86.6. Use a stoploss of 83.42 and if this stock hits its stoploss, then it can fall down till 81.95
Share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Target | 73.68 |
Downside Target | 75.40 |
Downside Target | 80.52 |
Upside Target | 85.04 |
Upside Target | 85.75 |
Upside Target | 86.10 |
Upside Target | 86.13 |
Upside Target | 86.24 |
Upside Target | 88.74 |
Upside Target | 93.36 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
Target Type | Value |
Downside Intraday Target | 82.72 |
Downside Intraday Target | 81.35 |
Upside Intraday Target | 85.85 |
Upside Intraday Target | 87.61 |
Upside Intraday Target | 84.48 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Weekly Closing Price | Open | High | Low | Volume |
19 Fri Jul 2024 | 84.09 | 85.19 | 86.24 | 83.11 | 0.996 times |
12 Fri Jul 2024 | 85.02 | 81.71 | 85.75 | 81.37 | 4.366 times |
05 Fri Jul 2024 | 81.45 | 82.82 | 82.82 | 80.53 | 0.469 times |
03 Wed Jul 2024 | 80.98 | 82.83 | 84.08 | 80.60 | 0.27 times |
28 Fri Jun 2024 | 82.33 | 84.28 | 86.10 | 82.15 | 0.33 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
Date | Monthly Closing Price | Open | High | Low | Volume |
19 Fri Jul 2024 | 84.09 | 82.83 | 86.24 | 80.53 | 0.207 times |
28 Fri Jun 2024 | 82.33 | 75.75 | 86.13 | 75.40 | 2.011 times |
31 Fri May 2024 | 75.07 | 81.07 | 85.04 | 73.68 | 1.046 times |
30 Tue Apr 2024 | 80.76 | 86.98 | 93.36 | 80.52 | 1.65 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term and the buy signal is strong.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Biomarin Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 83.91 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term and the buy signal is strong.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Biomarin Pharmaceutical in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 83.91 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.